These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 19880214

  • 1. Preparation and immunogenicity of capsular polysaccharide-surface adhesin A (PsaA) conjugate of Streptococcuspneumoniae.
    Lin H, Lin Z, Meng C, Huang J, Guo Y.
    Immunobiology; 2010 Jul; 215(7):545-50. PubMed ID: 19880214
    [Abstract] [Full Text] [Related]

  • 2. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H, Peng Y, Lin Z, Zhang S, Guo Y.
    Microb Pathog; 2015 Jul; 83-84():35-40. PubMed ID: 25959527
    [Abstract] [Full Text] [Related]

  • 3. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J, Sun T, Wang D, Dong Y, Xu M, Hou H, Kong FT, Liang C, Gu T, Chen P, Sun S, Lv X, Jiang C, Kong W, Wu Y.
    Immunol Invest; 2015 Jul; 44(5):482-96. PubMed ID: 26107747
    [Abstract] [Full Text] [Related]

  • 4. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO, Ding X, Briles DE, Jacobs MR, Greenspan NS.
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [Abstract] [Full Text] [Related]

  • 5. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA).
    Talkington DF, Brown BG, Tharpe JA, Koenig A, Russell H.
    Microb Pathog; 1996 Jul; 21(1):17-22. PubMed ID: 8827703
    [Abstract] [Full Text] [Related]

  • 6. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH, Dai WJ, Chen B, Fan XY.
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [Abstract] [Full Text] [Related]

  • 7. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

  • 8. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
    Chen X, Li B, Yu J, Zhang Y, Mo Z, Gu T, Kong W, Zhang Y, Wu Y.
    Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
    [Abstract] [Full Text] [Related]

  • 9. Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice.
    Gor DO, Ding X, Li Q, Schreiber JR, Dubinsky M, Greenspan NS.
    Infect Immun; 2002 Oct; 70(10):5589-95. PubMed ID: 12228286
    [Abstract] [Full Text] [Related]

  • 10. Immunogenic protein contaminants in pneumococcal vaccines.
    Yu J, Briles DE, Englund JA, Hollingshead SK, Glezen WP, Nahm MH.
    J Infect Dis; 2003 Mar 15; 187(6):1019-23. PubMed ID: 12660950
    [Abstract] [Full Text] [Related]

  • 11. Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli.
    De BK, Sampson JS, Ades EW, Huebner RC, Jue DL, Johnson SE, Espina M, Stinson AR, Briles DE, Carlone GM.
    Vaccine; 2000 Mar 06; 18(17):1811-21. PubMed ID: 10699329
    [Abstract] [Full Text] [Related]

  • 12. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
    Xu J, Dai W, Wang Z, Chen B, Li Z, Fan X.
    Clin Vaccine Immunol; 2011 Jan 06; 18(1):75-81. PubMed ID: 21047997
    [Abstract] [Full Text] [Related]

  • 13. Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model.
    Whaley MJ, Sampson JS, Johnson SE, Rajam G, Stinson-Parks A, Holder P, Mauro E, Romero-Steiner S, Carlone GM, Ades EW.
    Vaccine; 2010 Apr 19; 28(18):3071-5. PubMed ID: 20206671
    [Abstract] [Full Text] [Related]

  • 14. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
    Arévalo MT, Xu Q, Paton JC, Hollingshead SK, Pichichero ME, Briles DE, Girgis N, Zeng M.
    FEMS Immunol Med Microbiol; 2009 Apr 19; 55(3):346-51. PubMed ID: 19291171
    [Abstract] [Full Text] [Related]

  • 15. [Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection].
    Zhang J, Cui YL, Jiang YM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May 19; 19(5):583-589. PubMed ID: 28506354
    [Abstract] [Full Text] [Related]

  • 16. Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.
    Wang S, Li Y, Shi H, Scarpellini G, Torres-Escobar A, Roland KL, Curtiss R.
    Infect Immun; 2010 Jul 19; 78(7):3258-71. PubMed ID: 20479086
    [Abstract] [Full Text] [Related]

  • 17. Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age.
    Schmid P, Selak S, Keller M, Luhan B, Magyarics Z, Seidel S, Schlick P, Reinisch C, Lingnau K, Nagy E, Grubeck-Loebenstein B.
    Vaccine; 2011 May 23; 29(23):3982-9. PubMed ID: 21481328
    [Abstract] [Full Text] [Related]

  • 18. [Improvement of immunogenicity of Streptococcus pneumoniae psaA DNA vaccine by prime and boost strategy].
    Zhang DG, Wang ZM, Xu JH, Chen B, Dai WJ, Fan XY.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Sep 23; 44(9):762-6. PubMed ID: 20079102
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity and protective efficacy of DnaJ (hsp40) of Streptococcus pneumoniae against lethal infection in mice.
    Khan MN, Bansal A, Shukla D, Paliwal P, Sarada SK, Mustoori SR, Banerjee PK.
    Vaccine; 2006 Sep 11; 24(37-39):6225-31. PubMed ID: 16797798
    [Abstract] [Full Text] [Related]

  • 20. Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole-cell inactivated pneumococcal vaccine.
    David SC, Laan Z, Minhas V, Chen AY, Davies J, Hirst TR, McColl SR, Alsharifi M, Paton JC.
    Immunol Cell Biol; 2019 Sep 11; 97(8):726-739. PubMed ID: 31050022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.